SLX1A/B_SLX1 Activators

ATM Kinase Inhibitor, VE-821, NU7441, UCN-01, and AZD7762 disrupt the signaling cascades that manage the cellular response to DNA damage, which may result in an increased reliance on alternative repair mechanisms involving SLX1A/B_SLX1. Additionally, chemicals like aphidicolin and hydroxyurea create replication stress by targeting DNA synthesis, which can inadvertently lead to a heightened activity of DNA repair pathways that SLX1A/B_SLX1 is a part of.

Compounds such as camptothecin and etoposide, which induce DNA breaks by inhibiting topoisomerase enzymes, necessitate robust DNA repair responses that could engage SLX1A/B_SLX1. Moreover, PARP inhibitors like olaparib shift the cellular dependency towards alternate DNA repair pathways when single-strand break repair is compromised, possibly increasing the functional demand on SLX1A/B_SLX1. Mirin's inhibition of MRE11 affects the MRN complex, a critical sensor and initiator of DNA repair, which can lead to a compensatory upsurge in SLX1A/B_SLX1 activity. The CHK1 inhibitor UCN-01 and the dual CHK1/CHK2 inhibitor AZD7762 can also induce an accumulation of DNA damage, which may lead to a greater engagement of SLX1A/B_SLX1 in the DNA repair process.